The 21st Century Cures Act is now wrapping up in Congress and headed to the President’s desk. It would profoundly change how the Food and Drug Administration goes about its principal work of approving drugs and medical devices. Dr. Tom Coburn, former Oklahoma senator and now a senior fellow at the Manhattan Institute, joins Federal Drive with Tom Temin on the bill and its goals.
The 21st Century Cures Act, with rare bipartisan support, was supposed to modernize the Food and Drug Administration. The hiring freeze changed things up. Seth Rothman, a partner at the law firm Hughes, Hubbard and Reed, joined Federal Drive with Tom Temin to explain what may be happening now.
After earning its own authority from Congress, the Food and Drug Administration is developing an alternative pay and personnel system for 38 occupations.